Timothy Bettington serves as the Executive Vice President of Global Strategy and Market Development at Elanco Animal Health Inc., a leading global animal health company. In his role, Bettington is responsible for shaping the company's strategic direction and driving growth through innovative market development initiatives. He plays a crucial role in identifying and capitalizing on emerging opportunities within the animal health industry, leveraging his extensive experience and insights to guide Elanco's global expansion efforts. Before joining Elanco, Bettington held various leadership positions in the pharmaceutical and healthcare sectors. His career began at Eli Lilly and Company, where he spent over two decades in roles of increasing responsibility, including Vice President of Global Marketing and Business Development. During his tenure at Eli Lilly, Bettington demonstrated a keen ability to develop and execute successful strategies that drove significant growth and market share gains. His expertise in strategic planning, market analysis, and business development has been instrumental in his success and has earned him a reputation as a visionary leader in the industry. At Elanco, Bettington has been instrumental in the company's transformation into a standalone entity following its spin-off from Eli Lilly in 2019. He has played a key role in developing and implementing Elanco's long-term growth strategy, which includes expanding the company's portfolio of innovative products and services, as well as strengthening its presence in key markets worldwide. Under his leadership, Elanco has successfully launched several new products and has made strategic acquisitions to enhance its capabilities and drive future growth. Bettington's contributions have been vital to Elanco's success, and his vision and leadership continue to guide the company as it seeks to improve the health and well-being of animals around the world.